Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    18378608 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)
2 Completed Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
Condition: Colorectal Adenoma
Intervention: Drug: Celecoxib
3 Completed Laser and Medical Treatment of Diabetic Macular Edema
Condition: Macular Degeneration
Intervention: Drug: Celecoxib (Celebrex)
4 Active, not recruiting Selenium for Prevention of Adenomatous Colorectal Polyps
Conditions: Colorectal Cancer;   Adenomatous Colorectal Polyps;   Precancerous Condition
Intervention: Drug: Selenium
5 Unknown  Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: quality-of-life assessment

Indicates status has not been verified in more than two years